Nagendran Sukumar

CIK 00016651244 companiesDALLAS, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001665124

Recent Transactions

50 trades

Exercise/Conversion
Taysha Gene Therapies, Inc.$TSHA
Employee Stock Option (right to buy)
2026-01-12−111,324→ 111,359 total
Award
Taysha Gene Therapies, Inc.$TSHA
Employee Stock Option (right to buy)
2026-01-12+274,000→ 274,000 total
Sale
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2026-01-12$4.71/sh−200,000→ 1,006,439 total
Exercise/Conversion
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2026-01-12$1.71/sh+88,676→ 1,206,439 total
Award
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2026-01-12+427,000→ 1,433,439 total
Exercise/Conversion
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2026-01-12$0.70/sh+111,324→ 1,117,763 total
Exercise/Conversion
Taysha Gene Therapies, Inc.$TSHA
Employee Stock Option (right to buy)
2026-01-12−88,676→ 474,941 total
Sale
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2025-12-01$4.51/sh−260,047→ 1,006,439 total
Exercise/Conversion
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2025-12-01$1.71/sh+260,047→ 1,266,486 total
Exercise/Conversion
Taysha Gene Therapies, Inc.$TSHA
Employee Stock Option (right to buy)
2025-12-01−260,047→ 563,617 total
Exercise/Conversion
Taysha Gene Therapies, Inc.$TSHA
Employee Stock Option (right to buy)
2025-11-28−70,172→ 222,683 total
Exercise/Conversion
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2025-11-28$1.71/sh+39,953→ 1,116,564 total
Sale
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2025-11-28$4.75/sh−110,125→ 1,006,439 total
Exercise/Conversion
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2025-11-28$0.70/sh+70,172→ 1,076,611 total
Exercise/Conversion
Taysha Gene Therapies, Inc.$TSHA
Employee Stock Option (right to buy)
2025-11-28−39,953→ 823,664 total
Exercise/Conversion
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2025-09-10$0.70/sh+41,150→ 1,206,439 total
Exercise/Conversion
Taysha Gene Therapies, Inc.$TSHA
Employee Stock Option (right to buy)
2025-09-10−41,150→ 292,855 total
Sale
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2025-09-10$3.23/sh−200,000→ 1,006,439 total
Sale
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2025-08-21$2.85/sh−57,054→ 1,165,289 total
Award
Solid Biosciences Inc.$SLDB
Director Stock Option (Right to Buy)
2025-06-12+77,500→ 77,500 total
Award
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2025-01-02+324,500→ 1,222,343 total
Award
Taysha Gene Therapies, Inc.$TSHA
Employee Stock Option (right to buy)
2025-01-02+324,500→ 324,500 total
Award
Solid Biosciences Inc.$SLDB
Director Stock Option (Right to Buy)
2024-06-11+34,400→ 34,400 total
Award
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2024-01-02+863,617→ 897,843 total
Award
Taysha Gene Therapies, Inc.$TSHA
Employee Stock Option (right to buy)
2024-01-02+863,617→ 863,617 total
Award
Taysha Gene Therapies, Inc.$TSHA
Employee Stock Option (right to buy)
2023-12-14+334,005→ 334,005 total
Award
Solid Biosciences Inc.$SLDB
Director Stock Option (Right to Buy)
2023-06-06+9,650→ 9,650 total
Purchase
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2023-05-16$0.68/sh+5,000→ 34,226 total
Award
Taysha Gene Therapies, Inc.$TSHA
Stock Option (right to buy)
2022-12-30+790,093→ 790,093 total
Award
Solid Biosciences Inc.$SLDB
Director Stock Option (Right to Buy)
2022-12-13+9,650→ 9,650 total
Award
Taysha Gene Therapies, Inc.$TSHA
Stock Option (right to buy)
2022-06-17+15,500→ 15,500 total
Award
Solid Biosciences Inc.$SLDB
Director Stock Option (Right to Buy)
2022-06-07+51,000→ 51,000 total
Purchase
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2022-02-02$8.01/sh+10,000→ 29,226 total
Award
Taysha Gene Therapies, Inc.$TSHA
Stock Option (right to buy)
2021-06-17+15,500→ 15,500 total
Award
Solid Biosciences Inc.$SLDB
Director Stock Option (Right to Buy)
2021-06-16+30,000→ 30,000 total
Conversion
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2020-09-28+19,226→ 19,226 total
Conversion
Taysha Gene Therapies, Inc.$TSHA
Series B Preferred Stock
2020-09-28−17,647→ 0 total
Award
Taysha Gene Therapies, Inc.$TSHA
Stock Option (right to buy)
2020-09-23+31,000→ 31,000 total
Award
Solid Biosciences Inc.$SLDB
Director Stock Option (Right to Buy)
2020-06-16+10,000→ 10,000 total
Award
Solid Biosciences Inc.$SLDB
Director Stock Option (Right to Buy)
2020-06-16+30,000→ 30,000 total
Award
Solid Biosciences Inc.$SLDB
Common Stock
2019-07-25$4.65/sh+32,258→ 34,258 total
Award
Solid Biosciences Inc.$SLDB
Director Stock Option (Right to Buy)
2019-06-13+10,000→ 10,000 total
Award
Solid Biosciences Inc.$SLDB
Director Stock Option (Right to Buy)
2018-12-13+17,240→ 17,240 total
Award
Solid Biosciences Inc.$SLDB
Director Stock Option (Right to Buy)
2018-09-12+2,760→ 2,760 total
Award
AveXis, Inc.
Performance Stock Units (Right to Buy)
2018-05-15+9,906→ 9,906 total
Disposition to Issuer
AveXis, Inc.
Performance Stock Units (Right to Buy)
2018-05-15−9,906→ 0 total
Disposition to Issuer
AveXis, Inc.
Common Stock
2018-05-15−3,800→ 0 total
Disposition to Issuer
AveXis, Inc.
Stock Option (Right to Buy)
2018-05-15−178,494→ 0 total
Disposition to Issuer
AveXis, Inc.
Stock Option (Right to Buy)
2018-05-15−37,750→ 0 total
Disposition to Issuer
AveXis, Inc.
Stock Option (Right to Buy)
2018-05-15−25,200→ 0 total

Companies

Recent Filings

Address

C/O TAYSHA GENE THERAPIES, INC. 3000 PEGASUS PARK DRIVE, SUITE 1430

DALLAS, TX, 75247

View on SEC.gov